📰 Ian Miscampbell News
Ian Miscampbell News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ian Miscampbell. Real-time updates on events, politics, business and more.
July 18, 2023
/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pursuing a differentiated approach to develop next generation Chimeric Antigen...
March 17, 2023
GOSH will collaborate with Leucid at the Zayed Centre for Research into Rare Disease in Children - News - PharmaTimes
March 17, 2023
GOSH and Leucid Bio will manufacture a novel lateral CAR targeting NKG2D ligands, under a first-of-its-kind manufacturing agreement.
March 16, 2023
/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pursuing a differentiated approach to develop next generation Chimeric Antigen...
February 16, 2023
Proprietary Lateral CAR Platform achieved pre-clinical proof-of-concept data demonstrating prolonged disease-free survival compared to other CAR T-cell products.Lead programme, LEU011 has completed
October 22, 2021
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
October 21, 2021
/PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces...